The sarcomatous portion of the recurrence is distinctly astrocytic and clonally derived from the initial IDH-mutant astrocytoma, as demonstrated by an identical 17p CnLOH break-point and IDH1-R132C point mutations. Here, IDH2 is linked to astrocytoma (excluding glioblastoma).